# Efficacy and Safety of Endovascular Therapy with Common Femoral Artery Endarterectomy Site Access in Patients with Lower Extremity Artery Disease

## TL;DR

This study shows that using a specific artery access site improves the safety and success of blood vessel treatments in patients with leg artery disease.

## Contribution

Demonstrates the safety and efficacy of using the common femoral artery endarterectomy site for endovascular therapy in LEAD patients.

## Key findings

- Technical success of endovascular therapy was achieved in 97% of procedures.
- All punctures were technically successful, with minimal complications like hematoma.
- Median puncture and hemostasis times were 4 and 13 minutes, respectively.

## Abstract

The purpose of this study was to evaluate the results of endovascular therapy (EVT) with common femoral artery (CFA) endarterectomy site access for lower extremity artery disease (LEAD).

Records were reviewed retrospectively for patients who underwent EVT with CFA endarterectomy site access from 2014 to 2023 at 7 hospitals.

A total of 74 EVT procedures with CFA endarterectomy site access were performed in 65 patients with LEAD. The median [interquartile range] interval between CFA endarterectomy and the first EVT access was 435 [237–1153] days. Technical success of EVT was achieved in 72 procedures (97%). Technical success of the puncture was achieved in all 74 procedures (100%). The median [interquartile range] puncture time and hemostasis time were 4 [2–6] and 13 [10–20] min, respectively. Two cases (3%) had access site hematoma, which was cured with conservative treatment.

The CFA after endarterectomy may be a safe and suitable access site for EVT.